CYTOGENETIC AND CELL- SURFACE MARKER STUDIES IN TWO NON-HODGKIN'S LYMPHOMATA OF T-CELL ORIGINREEVES BR; STATHOPOULOS G.1976; HUM. GENET.; GERM.; DA. 1976; VOL. 31; NO 2; PP. 203-210; BIBL. 1 P. 1/2Article

FORMATION OF MOUSE OR SHEEP RED-BLOOD-CELL ROSETTES BY LYMPHOCYTES FROM NORMAL AND LEUKAEMIC INDIVIDUALS = FORMATION DE ROSETTES AVEC DES HEMATIES DE SOURIS OU DE MOUTON PAR LES LYMPHOCYTES PROVENANT D'INDIVIDUS NORMAUX OU LEUCEMIQUESSTATHOPOULOS G; ELLIOTT EV.1974; LANCET; G.B.; DA. 1974; NO 7858; PP. 600-601; BIBL. 8 REF.Article

SURFACE CHARACTERISTICS OF LYMPHOMA CELLS IN RELATION TO TREATMENT, RESPONSE AND SURVIVAL.STATHOPOULOS G; KAY HEM; HAMLIN IME et al.1978; EUROP. J. CANCER; G.B.; DA. 1978; VOL. 14; NO 5; PP. 479-483; BIBL. 11 REF.Article

THE T AND B LYMPHOCYTE CONTENT OF LYMPH NODES AND SPLEEN IN HODGKIN'S DISEASE.STATHOPOULOS G; PAPAMICHAIL M; PECKHAM MJ et al.1977; BRIT. J. EXPER. PATHOL.; G.B.; DA. 1977; VOL. 58; NO 6; PP. 712-716; BIBL. 25 REF.Article

Epidemiology and pathogenesis of esophageal cancer: Management and its controversial results (Review)STATHOPOULOS, G. P; TSIARAS, N.Oncology reports. 2003, Vol 10, Num 2, pp 449-454, issn 1021-335X, 6 p.Article

HUMAN CANCER. ITS CHARACTERIZATION AND TREATMENTDAVIS W ED; HARRAP KR ED; STATHOPOULOS G ED et al.1980; EXCERPTA MED., INT. CONGR. SER.; ISSN 0531-5131; NLD; DA. 1980; NO 484; XI-420 P.; BIBL. DISSEM.Conference Paper

PHARMACO-KINETICS OF FIRE CEPHALOSPORINS IN HEALTHY MALE VOLUNTEERS.PARADELIS AG; STATHOPOULOS G; THIANTHAPHYLLIDIS C et al.1977; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1977; VOL. 27; NO 11; PP. 2167-2170; ABS. ALLEM.; BIBL. 1/2 P.Article

LYMPHOCYTE: ERYTHROCYTE (L. E.) ROSETTES AS INDICATORS OF THE HETEROGENEITY OF LYMPHOCYTES IN A VARIETY OF MAMMALIAN SPECIESBRAGANZA CM; STATHOPOULOS G; DAVIES AJS et al.1975; CELL; U.S.A.; DA. 1975; VOL. 4; NO 2; PP. 103-106; BIBL. 16REF.Serial Issue

IMMUNOLOGICAL STUDIES IN A CASE OF T-CELL LEUKAEMIASTATHOPOULOS G; PAPAMICHAIL M; SHELDON P et al.1974; J. CLIN. PATHOL.; G.B.; DA. 1974; VOL. 27; NO 11; PP. 851-859; BIBL. 26REF.Article

IN VITRO COMPARISON OF KANAMYCIN, KANENDOMYCIN, GENTAMYCIN, AMIKACIN, SISOMICIN, AND DIBEKACIN AGAINST 200 STRAINS OF PSEUDOMONAS AERUGINOSAPARADELIS AG; DOUBOYAS J; STATHOPOULOS G et al.1978; ANTIMICROB. AGENTS CHEMOTHERAPY; USA; DA. 1978; VOL. 14; NO 3; PP. 514-515; BIBL. 2 REF.Article

Liposomal Cisplatin Dose Escalation for Determining the Maximum Tolerated Dose and Dose-limiting Toxicity: A Phase I StudySTATHOPOULOS, G. P; RIGATOS, S. K; STATHOPOULOS, J et al.Anticancer research. 2010, Vol 30, Num 4, pp 1317-1321, issn 0250-7005, 5 p.Article

Subcutaneous emphysema following PEGSTATHOPOULOS, G; RUDBERG, M. A; HARIG, J. M et al.Gastrointestinal endoscopy. 1991, Vol 37, Num 3, pp 374-376, issn 0016-5107, 3 p.Article

D-dimer levels in pleural effusionsDIKENSOY, O; STATHOPOULOS, G. T; ZHU, Z et al.Respiratory medicine. 2006, Vol 100, Num 8, pp 1337-1341, issn 0954-6111, 5 p.Article

Effectiveness of Paclitaxel and carboplatin combination in heavily pretreated patients with head and neck cancersSTATHOPOULOS, G. P; RIGATOS, S; PAPAKOSTAS, P et al.European journal of cancer (1990). 1997, Vol 33, Num 11, pp 1780-1783, issn 0959-8049Article

Erfect of adriamycin, 5-fluorouracil and mitomycin-C combination chemotherapy in advanced colorectal cancerSTATHOPOULOS, G. P; STERGIOU, G. S; GOLEMATIS, B et al.Oncology. 1995, Vol 52, Num 4, pp 306-309, issn 0030-2414Article

Diagnostic value of anti-αFP antibody levels in a metastatic germ cell tumor of unknown primary siteMALAMITSI, J; STATHOPOULOS, G; KITTAS, C et al.Anticancer research. 1999, Vol 19, Num 3B, pp 2201-2204, issn 0250-7005Article

Rapidly progressive sclerosing cholangitis following surgical treatment of pancreatic pseudotumorSTATHOPOULOS, G; NOURMAND, A. D; BLACKSTONE, M et al.Journal of clinical gastroenterology. 1995, Vol 21, Num 2, pp 143-148, issn 0192-0790Article

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancerSTATHOPOULOS, G. P; ANTONIOU, D; DIMITROULIS, J et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 945-950, issn 0344-5704, 6 p.Article

Granulocyte colony-stimulating factor expression as a prognostic biomarker in non-small cell lung cancerSTATHOPOULOS, G. P; ARMAKOLAS, A; TRANGA, T et al.Oncology reports. 2011, Vol 25, Num 6, pp 1541-1544, issn 1021-335X, 4 p.Article

Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III StudySTATHOPOULOS, G. P; BATZIOU, C; TRAFALIS, D et al.Oncology. 2010, Vol 78, Num 5-6, pp 376-381, issn 0030-2414, 6 p.Article

A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patientsHARDY, J; DALY, S; MCQUADE, B et al.Supportive care in cancer. 2002, Vol 10, Num 3, pp 231-236, issn 0941-4355Article

Angiosarcoma of the heart : Case report and review of the literatureBATZIOS, S; MICHALOPOULOS, A; KAKLAMANIS, L et al.Anticancer research. 2006, Vol 26, Num 6C, pp 4837-4842, issn 0250-7005, 6 p.Article

Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients : a phase II studySTATHOPOULOS, G. P; TSAVDARIDIS, D; MALAMOS, N. A et al.Cancer chemotherapy and pharmacology. 2005, Vol 56, Num 5, pp 487-491, issn 0344-5704, 5 p.Article

Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatmentSTATHOPOULOS, G. P; DAFNI, U. G; MALAMOS, N. A et al.Anticancer research. 1999, Vol 19, Num 4C, pp 3543-3548, issn 0250-7005Article

Doxorubicin cardiotoxicity and serum lipid increase is prevented by dextrazoxane (ICRF-187)SAMELIS, G. F; STATHOPOULOS, G. P; KOTSARELIS, D et al.Anticancer research. 1998, Vol 18, Num 5A, pp 3305-3309, issn 0250-7005Article